The Business Research Company’s report on the Non-Therapeutic Biomolecules Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the non-therapeutic biomolecules industry?
The rapidly increasing number of research and laboratory testing is expected to propel the growth of the non-therapeutic biomolecules market going forward. Laboratory testing refers to the medical procedure that involves testing a sample of blood, urine, or other substance from the body to determine and monitoring of disease and draft a treatment plan, whereas research refers to the new knowledge is created, or current knowledge is creatively applied to produce new concepts, theories, and understandings. Non-therapeutic biomolecules in laboratory testing are used to measure the presence or concentration of a biomarker molecule that indicates disease, to enhance the sensitivity and specificity of the test. For instance, in July 2024, according to the National Health Service (NHS), a UK-based hospital and health care provider, diagnostic activity exceeded pre-pandemic levels in 2023, with a 21% increase in tests performed in May 2024 compared to the previous year. Therefore, the rapidly increasing number of research and laboratory testing is driving the growth of the non-therapeutic biomolecules market.
Access Your Free Sample of the Global Non-Therapeutic Biomolecules Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp
What is the estimated market size of the non-therapeutic biomolecules sector by 2029, based on current forecasts?
The non-therapeutic biomolecules market size has grown rapidly in recent years. It will grow from $30.76 billion in 2024 to $34.23 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increased research and development (R&D) investments, growing applications in research and diagnostics, rising awareness and adoption, strategic collaborations and partnerships, regulatory support.
The non-therapeutic biomolecules market size is expected to see rapid growth in the next few years. It will grow to $52.15 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to emerging market opportunities, advancements in data analytics and integration, growing focus on precision medicine, increasing investment in personalized healthcare, expanding application areas. Major trends in the forecast period include technological advancements, strategic collaborations, rising applications in agriculture, expanding role in industrial processes, customization and personalization.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp
#Who are the top players in the non-therapeutic biomolecules market?
Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.
#What are the major trends in the non-therapeutic biomolecules market?
Product innovations are a key trend gaining popularity in the non-therapeutic biomolecules market. Major companies operating in the market are focused on research and development for product innovations to sustain their position in the market. For instance, in January 2022, BASF SE, a Germany-based multinational chemical company partnered with Caregen, a Korean-based company operating in biomimetic peptide research and development and introduced the Peptovitae series manufactured using liposome-encapsulation technology to expand its dermo-cosmetics portfolio to address a broad range of skin concerns with innovative and differentiated solutions. Liposomal encapsulation is a technique that uses fats to deliver essential vitamins or medications to specific body sections in tiny bubbles without affecting other body parts. The Peptovitae series addresses a wider range of skin concerns than are traditionally associated with the use of peptides such as signs of aging, enhancing the brightness of the skin, soothing skin prone to dryness and itching, and moisturizing skin.
Which geography holds the highest non-therapeutic biomolecules market share?
Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report
How do different segments contribute to the overall expansion of the non-therapeutic biomolecules market?
The non-therapeutic biomolecules market covered in this report is segmented –
1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)
Subsegments:
1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes
2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors
3) By Plasmids: Research Plasmids, Expression Plasmids
4) By Peptides: Antimicrobial Peptides, Signaling Peptides
5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides
6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8769
What defines the structure and scope of the non-therapeutic biomolecules market?
Non-therapeutic biomolecule refers to the organic compounds created by cells and living things. These compounds come in a wide range of shapes and sizes and carry out a wide variety of tasks in body functioning.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
